Arindam Bose

Arindam Bose

Corporate Officer/Principal at AKERO THERAPEUTICS, INC.

Net worth: 49 720 $ as of 31/05/2026

73 year
Health Technology
Commercial Services
Consumer Services

Profile

Arindam N.
Bose
currently works at Signet Healthcare Partners LLC, as Advisor from 2019, American Chemical Society, as Member, American Institute of Chemical Engineers, as Trustee, Akero Therapeutics, Inc., as Vice President-Process Development from 2019, and Abiologics LLC, as Consultant from 2016.
Dr. Bose also formerly worked at Pharmaceutical Research & Manufacturers of America, as Chairman-Biologics, Dyadic International, Inc., as Independent Director from 2016 to 2025, Pfizer Inc., as VP-Biotherapeutics Pharmaceutical Sciences from 2010 to 2016, and Battelle Memorial Institute, as Research Scientist from 1980 to 1982.
Dr. Bose received his doctorate degree from Purdue University, graduate degree from the University of Michigan, and undergraduate degree from Indian Institute of Technology Kanpur.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
20/06/2025 61,535 ( 0.17% ) 49 720 $ 31/05/2026

Arindam Bose active positions

CompaniesPositionStart
AKERO THERAPEUTICS, INC. Corporate Officer/Principal 01/01/2019
Consultant / Advisor 01/04/2016
Consultant / Advisor 01/11/2019
Director/Board Member -
Corporate Officer/Principal -

Former positions of Arindam Bose

CompaniesPositionEnd
DYADIC INTERNATIONAL, INC. Director/Board Member 20/06/2025
PFIZER INC. Corporate Officer/Principal 01/03/2016
Chief Tech/Sci/R&D Officer 01/06/1982
Corporate Officer/Principal -
See the detail of Arindam Bose's experience

Training of Arindam Bose

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

94

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Commercial Services

Health Services

Finance

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!